Market Scenario

The Poland Aesthetic Injectables Market is estimated to witness a growth of US$ 14.42 Million during 2022-2030 and is estimated to reach US$ 30.65 Million by 2030, registering a CAGR of 8.3% during the forecast period. Market growth is attributed to factors such as increasing awareness among people about wellness, health, and beauty, the rising market for cosmetic surgeries, and an increase in the number of certified dermatologists in the country. Moreover, technological advancements are also playing a major role in the development of the market as the demand for modern non-surgical methods has surpassed that for traditional ones in recent times. 

Competitive Landscape:

The cumulative market share of key players in the market is around 42.9%. Some of the top players in the market are Allergan, Galderma Laboratories, L.P., Fotona D.O.O, and Merz Aesthetics. Market players are adopting strategies like mergers, acquisitions, and new product launches to stay competitive in the market.

To Get more Insights,  Request A Free Sample 

 Recent strategies adopted by key market players include:

• In February 2022, Merz Aesthetics announced the launch of Radiesse Lidocaine, an injectable implant for deep injection for soft tissue augmentation. The injectable is aimed at improving moderate to severe loss of jawline contour for individuals aged over 21 years. This is the first and only injectable treatment for improving jawline contour that has received FDA approval and the company’s first and only calcium hydroxylapatite offering.
• In April 2016, Mentor Worldwide LLC announced its partnership with a renowned cosmetic company Galderma Pvt. Lid., they are a global pioneer in medical treatments for skin health. Through the partnership, the companies would offer a range of products for healthcare practitioners who have patients seeking aesthetic injectable procedures, including breast augmentation.
• In December 2018, Galderma Laboratories, L.P. announced an extension of its partnerships in the United States with professional skincare brands REVISION SKINCARE, ALASTIN Skincare, and SENTÉ. Through the collaboration, aesthetic providers would receive skincare products to provide to their patients for use as part of their ongoing beauty routines with a qualifying purchase of Galderma dermal fillers.

Factors leading to the growing presence of players in the Poland Aesthetic Injectables Market are:

Growing cosmetic market in the EU 

The merging of Poland in the EU has favored the growth of the EU cosmetic market. As the government focuses on improving the trade relations with the region and developing advanced healthcare systems in Poland, the demand for cosmetic procedures is expected to increase in Poland. The rising awareness among the population about their physical appearance, wellness, and health, and the subsequent increase in spending on cosmetics and beauty procedures, is also expected to favor market growth. Modern biochemical, chemical, and medical solutions are helping offer safer and more efficient plastic surgeries, driving the demand for modern cosmetic techniques. 

Rise in medical tourism 

The medical tourism sector has been growing at a significant pace in Poland over the past few years, leading to a notable increase in the number of medical procedures performed. Poland has been attracting more than 600 thousand medical tourists till now from the Baltic and Eastern European regions. The low cost of cosmetic treatments is one of the key factors contributing to the increasing footfall of medical tourists in Poland; the cost of medical procedures is almost one-third of other European countries. The government is also increasing the spending on healthcare and plans to take it to nearly 6% of the country’s GDP gradually by the estimate till 2028. 

Current trends in the market

The booming population creating opportunities for the HA market 

Dermal fillers are the most popular and nonsurgical injectable aesthetic procedures and are mainly used to address soft tissue abnormalities of the face. Dermal fillers based on Hyaluronic Acid (HA) are often used for aesthetic operations such as nasolabial folds, eye wrinkles, dark circles, scar repair, and rejuvenation. Moreover, hyaluronic acid injections are simple to use, effective, and relatively inexpensive. 

HA fillers are shorter-acting than biostimulators but are fully reversible with an injection of hyaluronidase, which neutralizes hyaluronic acid. Full results appear within days. As a result, the demand for HA injections has increased significantly in recent years and is expected to rise over the forecast period as well. The demand for biostimulators is also growing and is expected to grow at a higher CAGR than HA, at 9.1% over the forecast period. 

Factors restraining market growth

Lack of dermatologists and cosmetic surgeons 

Poland faces a lack of healthcare service providers, leaving a relatively high percentage of the Polish population with unmet medical needs. Access to health care is further hampered by high out-of-pocket spending, a shortage of healthcare professionals, and a relatively high number of uninsured people. The lack of beauty clinics with skilled doctors and medical staff also negatively impacts the number of cosmetic procedures and injectables procedures performed in Poland per year. However, the government is taking progressive steps to educate more surgeons and strengthen the healthcare facilities in Poland, which could help the market grow in the future.

Impact of COVID-19 

The COVID-19 pandemic negatively impacted the Poland aesthetic injectables market as fewer people underwent cosmetic and plastic surgeries. The government-imposed restrictions during covid outbreak, lockdowns, and the fear of contracting the virus in public places dampened public enthusiasm for undergoing cosmetics treatments. This, in turn, reduced the number of visitors and patients in many cosmetic clinics, dermatology clinics, and hospitals. Many people canceled their appointments and sought to stay away from crowded places. The pandemic disrupted the industry's rate of innovation, revenue, and popularity in Poland. Moreover, beauty salons and beauty clinics were closed due to strict lockdown orders from the government.

Market Segment Analysis

By Product Type 

Based on product type, the hyaluronic acid fillers segment held the highest share of 74.2% in 2021. Hyaluronic acid is widely used in the treatment of the signs of ageing and shows immediate results. Injectable HA is widely used to reduce the appearance of fine lines, facial folds, and wrinkles and to create structure, framework, and add volume to the face and lips. 

By Route of Administration

In terms of route of administration, the subcutaneous segment is expected to register the highest CAGR of 8.9% over the forecast period. The segment also held the largest share of 53.5% in 2021 and is expected to retain dominance with a net increase of 2.9% by the end of the forecast period. This can be attributed to the higher demand for subcutaneous skincare treatments as a short needle is used to inject the drug into the tissue layer between the skin and the muscle. The injectables are injected to produce results directly only on the skin and can start showing results within a week.

 To Understand More About this Research:  Request A Free Sample 

By Application

In terms of application, the wrinkle reduction segment held the highest market share of 24.1% in 2021. This can be attributed to the increasing demand for wrinkle reduction injectables from men and women worldwide. Wrinkles are often the first signs of ageing and are among the most common skin-related concerns among middle-aged people. The rising expenditure of an increasing number of people across the globe on aesthetic treatments for wrinkle reduction is expected to drive the segment.

By Packaging Type

In terms of packaging type, the vials segment is expected to register the highest CAGR of 9.2% over the forecast period. Vials have been chiefly used for pharmaceutical packaging for many years and maintain a strong position in the industry. The segment is followed by the syringes and ampules segments, which are expected to register CAGRs of 8% and 6.9%, respectively, over the forecast period. 

End User Analysis

Based on end user, the dermatology clinics segment holds the dominant position in the market, followed by hospitals and others. The dermatology clinics segment is expected to be valued at US$ 20.23 million in 2030 from US$ 10.13 million in 2021. The segment is also expected to register the highest CAGR of 8.7% over the forecast period. The preference of patients for dermatology clinics for cosmetic services is increasing gradually year on year because clinics offer a variety of services. Cosmetic dermatology is skin, hair, or body treatment designed to improve a patient's appearance and the dermatologist focuses on improving appearance rather than curing a disease.

Distribution Channel Analysis:

Based on distribution channel, the hospitals segment dominated the Poland aesthetic injectables market in terms of having the highest market share of 70.1% and Online Pharmacies having the highest CAGR of 9.7% followed by Retail Stores and then Hospital.

Segmentation Overview

The Poland aesthetic injectables market is segmented into:

By Product Type

• Hyaluronic Acid Fillers
• Biostimulator
  • Polymethylmethacrylate (PMMA)
  • Polylactic Acid
  • Calcium hydroxyapatite
  • Others

By Route of Administration

• Intravenous
• Intramuscular
• Subcutaneous

By Application

• Face Lift
• Lip Augmentation
• Scars Treatment
• Lipoatrophy Treatment
• Wrinkle Reduction
• Anti-Ageing Treatment
• Others

By Packaging Type

• Ampules
• Syringes
• Vials
• Cartridges
• Bottles

By End User

• Hospitals
• Dermatology Clinics
• Others

By Distribution Channel

• Hospital
• Retail Stores
• Online Pharmacies